Bradley E. Singer - 06 Jun 2024 Form 4 Insider Report for Redfin Corp (RDFN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 Jun 2024, 16:21:08 UTC
Prior SEC filing
20 May 2024
Next SEC filing
17 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Anthony Kappus, attorney-in-fact

Key filing fact

Bradley E. Singer filed Form 4 for Redfin Corp (RDFN) on 10 Jun 2024.

Key facts

  • This page summarizes Bradley E. Singer's Form 4 filing for Redfin Corp (RDFN).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 10 Jun 2024, 16:21.

Change

  • Previous filing in this sequence was filed on 20 May 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RDFN transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+25,423
Change %
Price
$0.000000
Shares after
25,423
Date
06 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,423
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted stock units convert into common stock on a one-for-one basis upon settlement.

Footnote F2

The restricted stock units will vest on June 09, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .